William Plovanic | Chief Financial Officer |
Andrew Rasdal | President and Chief Executive Officer |
Kelly Huang | President and Chief Operating Officer |
David Solomon | Roth Capital Partners |
Kyle Rose | Canaccord Genuity |
Ben Haynor | Alliance Global Partners |
Good day, ladies and gentlemen, and welcome to Obalon Therapeutics’ Third Quarter 2018 Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.